have been withdrawn in bladdercancer as a result. Gilead said Trodelvy’s safety profile in the TROPHY study is consistent with previous observations in metastatic UC and other tumour types.
Medscape Medical News, January 30, 2024 BladderCancer ... 2024 Gilead's Trodelvy Fails to Meet Main Goal in Lung Cancer Trial Gilead Sciences said on Monday its drug, Trodelvy, failed to ...
Results that may be inaccessible to you are currently showing.